Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

    NIH supports exploratory and early-stage research to develop selective methods or agents for undruggable targets in intractable human diseases; clinical trials are not allowed.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

    Funding available for preclinical studies in rare diseases to show effectiveness of proposed treatments for potential further development into clinical trials.

    HHS-NIH11Due Jun 2, 2027$275,000

    National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)

    Funding available for research on innovative drug and device treatments for mental disorders, substance use, and alcohol use, promoting collaboration between academia and industry through U01 mechanism.

    HHS-NIH11Due Feb 25, 2027

    Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

    NIH supports clinical projects that prepare rare disease therapies or diagnostics for trials through biomarkers, outcome measures, or disease characterization; clinical trials are not allowed.

    HHS-NIH11Due Feb 17, 2027$275,000

    Focused Technology Research and Development (R01 Clinical Trial Not Allowed)

    Supporting projects developing innovative technologies for biomedical research, advancing current capabilities for acquiring biomedical knowledge.

    HHS-NIH11Due Feb 5, 2027

    Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)

    NIH supports discovery of in vivo chemical probes for novel brain targets, with applicants expected to have validated starting compounds and bioassays; clinical trials are not allowed.

    HHS-NIH11Due Feb 5, 2027